Device Trial Radar · NCT01609738
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum
Last checked: Nov 19, 2026Latest source record: Apr 8, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Nov 2012
Primary completion
Feb 2015
Study completion Feb 2015
Sponsor
- Lead sponsor
- Maastricht University Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic Cardiac Rhythm and Heart Failure
- First posted
- Jun 1, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cardiac pacing is the only effective treatment for symptomatic bradycardia. The right ventricular apex (RVA) has become the most frequently used ventricular pacing site. However, RVA pacing has been shown to cause left ventricular (LV) dyssynchrony wich can lead to LV dysfunction and development of heart failure. Recent studies in animals have demonstrated that pacing at the LV septum induces significantly less ventricular dyssynchrony than RVA pacing and is able to improve LV function to a similar degree as biventricular (BiV) pacing. In addition it was shown that a LV septum lead can be placed permanently by driving a lead with extended helix from the RV side through the inter-ventricular septum into the LV endocardial layer. This was shown to be a feasible and safe procedure and lead stability was shown during four months of follow-up in otherwise healthy and active canines. LV septum pacing may therefore be a good treatment alternative in patients with symptomatic bradycardia, as well as patients with an indication for cardiac resynchronization therapy (CRT). The purpose of this study is to translate the findings from preclinical studies to the clinical situation by investigating the feasibility, long-term lead stability and safety of LV septum pacing by transvenous approach through the inter-ventricular septum in patients.
Conditions
- Left Ventricular Dysfunction
- Cardiac Conduction Defect
- Heart Failure
- Sick Sinus Syndrome
Interventions
Left ventricular septum pacing leadDevice
A left ventricular septum pacing lead is permanently placed by introducing a custom lead with extended helix transvenously and, after positioning it against the RV septum, driving it through the inter-ventricular septum into the LV endocardial layer.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of successful LV septum lead implantationsTime frame: Baseline and 6 months
- Change in sensing values, pacing threshold and lead impedanceTime frame: Baseline and 6 months
- Number of participants with procedure or lead related adverse eventsTime frame: Baseline and 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Maastricht University Medical Centre
Maastricht, Limburg, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.